The American Journal of Medicine
Volume 117, Issue 3 , Pages 208-210 , 1 August 2004

Beneficial response to interleukin 1 receptor antagonist in traps

References 

  1. Chae JJ , Komarow HD , Cheng J, et al.  Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to en. Mol Cell. 2003;11:591–604
  2. Frenkel J , Rijkers GT , Mandey SH, et al.  Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum. 2002;46:2794–2803
  3. Aksentijevich I , Nowak M , Mallah M, et al.  De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002;46:3340–3348
  4. Nuki G , Bresnihan B , Bear MB , McCabe D . Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002;46:2838–2846
  5. Hawkins PN , Lachmann HJ , McDermott MF . Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med. 2003;348:2583–2584
  6. Drewe E , McDermott EM , Powell PT, et al.  Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology (Oxford). 2003;42:235–239
  7. Drewe E , Powell RJ . Novel treatment for tumour necrosis factor receptor associated periodic syndrome (TRAPS): case history of experience with infliximab and sirolimus post etanercept. Clin Exp Rheumatol. 2002;20(suppl. 26):S71; (abstract)
  8. Hull KM , Drewe E , Aksentijevich I, et al.  The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore). 2002;81:349–368
  9. Simon A , van Deuren M , Tighe PJ, et al.  Genetic analysis as a valuable key to diagnosis and treatment of periodic Fever. Arch Intern Med. 2001;161:2491–2493
  10. Fleischmann RM . Addressing the safety of anakinra in patients with rheumatoid arthritis. Rheumatology (Oxford). 2003;42(Suppl 2):ii29–ii35

PII: S0002-9343(04)00255-4

doi: 10.1016/j.amjmed.2004.02.039

The American Journal of Medicine
Volume 117, Issue 3 , Pages 208-210 , 1 August 2004

Article Tools

* Image Usage & Resolution